BA
The Boeing Company
BA has the edge over DCH overall, supported by stronger fundamentals and lower modeled downside.
DCH
Dauch Corporation
DCH offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
DCH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Under pressure | |
| Weak |
DCH's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
DCH PE Valuation
DCH has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
DCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for DCH, with profitability improving. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over DCH on earnings quality, reporting a profit while its opponent remains loss making.
DCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.86 | — |
| Q3 2026 | -$1.33 | -491% |
| Q2 2026 | -$1.07 | -406% |
| Q1 2026 | -$0.75 | -517% |
| Q4 2025 | -$0.17 | -159% |
| Q3 2025 | $0.34 | +48% |
| Q2 2025 | $0.35 | +$0.35 |
| Q1 2025 | $0.18 | +$0.26 |
| Q4 2024 | $0.29 | +$0.58 |
DCH has swung to a loss: it lost $1.33 per share over the past year, after a profit the year before.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over DCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
DCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.9B | +93% |
| Q2 2026 | $3B | +92% |
| Q1 2026 | $2.4B | +69% |
| Q4 2025 | $1.4B | +0.2% |
| Q3 2025 | $1.5B | 0% |
| Q2 2025 | $1.5B | -5.9% |
| Q1 2025 | $1.4B | -12% |
| Q4 2024 | $1.4B | -5.6% |
DCH's revenue has grown year over year for five quarters in a row: $2.9B last quarter, up 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.5% | -0.8 points |
| Q2 2026 | 3.4% | -0.2 points |
| Q1 2026 | -1.4% | -4.4 points |
| Q4 2025 | -2.4% | -5.1 points |
| Q3 2025 | 3.2% | +0.5 points |
| Q2 2025 | 3.6% | -1.7 points |
| Q1 2025 | 3% | -1.8 points |
| Q4 2024 | 2.6% | +0.7 points |
DCH has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over DCH on cash generation, producing positive trailing cash flow while its opponent burns cash.
DCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $54.7M | -31% |
| Q2 2026 | $9.2M | -73% |
| Q1 2026 | -$168M | -$154.6M |
| Q4 2025 | $54.7M | -25% |
| Q3 2025 | $79.2M | +13% |
| Q2 2025 | $34.6M | -63% |
| Q1 2025 | -$13.4M | +$16.8M |
| Q4 2024 | $73.2M | +$76.3M |
DCH's free cash flow has turned negative after years in the green: −$49M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over DCH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
DCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +100K shares |
| 1 year | +100% | +119M shares |
| 3 years | +103% | +120M shares |
| 5 years | +108% | +123M shares |
| Available history | +112% | +125M shares |
DCH has 238M diluted shares, up 100% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $700,000 |
| Q2 2026 | $2M |
| Q1 2026 | $6.2M |
| Q4 2025 | $100,000 |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $2.7M |
| Q4 2024 | — |
DCH spent $9M buying back its own shares over the past year, about three times what it spent the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over DCH on leverage, with a lower net debt burden relative to earnings.
DCH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.0x | High |
| Q2 2026 | 6.0x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 3.0x | Elevated |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.0x | Moderate |
DCH's net debt is about 5.0 years of its operating earnings (EBITDA), up from 3.0 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
DCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 7.8 | Oversold |
DCH's weekly RSI is 39 (neutral) and its Stochastic is 8 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
DCH PE vs Industrials Sector
| Metric | DCH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
DCH has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
DCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.02 | 7.4% below |
| 20 week MA | $5.63 | 17% below |
| 50 week MA | $6.16 | 25% below |
| 100 week MA | $5.63 | 17% below |
| 200 week MA | $6.52 | 29% below |
DCH is in a downtrend: it's below all five of its weekly moving averages, and 29% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over DCH on returns for 2026, with the stronger performance.
DCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.6 | $8.23 | -23% |
| 2021 | $8.23 | $9.34 | +13% |
| 2022 | $9.34 | $7.65 | -18% |
| 2023 | $7.65 | $8.81 | +15% |
| 2024 | $8.81 | $5.86 | -33% |
| 2025 | $5.86 | $6.46 | +10% |
| 2026 YTD | $6.46 | $4.65 | -28% |
DCH has finished lower in three of the last six years. It's down 28% so far in 2026.